Position in BCYC
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$42,010
-$22,092 QoQ
Shares Held
9,054
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCYC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $3,031,079,822 across 242 Biotechnology names. BCYC ranks #174 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,955,764 | $873,326,855 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
732,054 | $565,614,201 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
934,881 | $309,324,075 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,362,872 | $161,316,968 | |
| 5 | INCY |
Incyte Corp
|
1,543,188 | $145,244,853 | |
| 6 | INSM |
INSMED Inc
|
787,079 | $128,703,157 | |
| 7 | ARGX |
Argenx SE
|
150,850 | $110,158,211 | |
| 8 | MRNA |
Moderna, Inc.
|
750,841 | $38,142,721 |
All Filings in BCYC
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $42,010 | 9,054 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $64,102 | 9,054 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,531,877 | 197,917 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,215,624 | 174,910 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,151,736 | 135,658 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,947,050 | 139,075 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $5,404,406 | 238,816 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $5,015,755 | 247,814 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $3,313,393 | 133,068 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $2,401,114 | 132,805 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $1,857,581 | 92,463 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,048,133 | 80,256 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $279,891 | 13,159 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $311,776 | 10,533 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $212,433 | 9,133 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $153,251 | 9,133 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $494,352 | 11,266 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $612,352 | 10,060 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $424,550 | 10,208 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $243,821 | 8,031 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||